Drugs Approved for Myeloproliferative Neoplasms or Myelodysplastic Syndromes
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for myeloproliferative neoplasms or myelodysplastic syndromes. The list includes generic and brand names. This page also lists common drug combinations used in myeloproliferative neoplasms or myelodysplastic syndromes. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in myeloproliferative neoplasms or myelodysplastic syndromes that are not listed here.
Drugs Approved for Myeloproliferative Neoplasms or Myelodysplastic Syndromes
- Adriamycin PFS (Doxorubicin Hydrochloride)
- Adriamycin RDF (Doxorubicin Hydrochloride)
- Arsenic Trioxide
- Azacitidine
- Besremi (Ropeginterferon Alfa-2b-njft)
- Cerubidine (Daunorubicin Hydrochloride)
- Clafen (Cyclophosphamide)
- Cyclophosphamide
- Cytarabine
- Cytosar-U (Cytarabine)
- Cytoxan (Cyclophosphamide)
- Dacogen (Decitabine)
- Dasatinib
- Daunorubicin Hydrochloride
- Decitabine
- Decitabine and Cedazuridine
- Doxorubicin Hydrochloride
- Fedratinib Hydrochloride
- Gleevec (Imatinib Mesylate)
- Imatinib Mesylate
- Imetelstat Sodium
- Inqovi (Decitabine and Cedazuridine)
- Inrebic (Fedratinib Hydrochloride)
- Ivosidenib
- Jakafi (Ruxolitinib Phosphate)
- Nilotinib
- Pacritinib Citrate
- Pemazyre (Pemigatinib)
- Pemigatinib
- Ropeginteferon Alfa-2b-njft
- Rubidomycin (Daunorubicin Hydrochloride)
- Ruxolitinib Phosphate
- Rytelo (Imetelstat Sodium)
- Sprycel (Dasatinib)
- Tarabine PFS (Cytarabine)
- Tasigna (Nilotinib)
- Tibsovo (Ivosidenib)
- Trisenox (Arsenic Trioxide)
- Vidaza (Azacitidine)
- Vonjo (Pacritinib Citrate)